Education
About Us
Working with TipRanks
Follow Us
Shane Barton Insider Profile
4 Followers
Shane Barton, VP & Corp. Contr at Precision BioSciences, holds 2.63K shares in BioAge Labs, Inc. (Ticker: BIOA), holds 27.50K shares in Precision BioSciences (Ticker: DTIL). Most recently, Shane Barton Bought ― shares of BioAge Labs, Inc. on Mar 10, 2025 for an estimated value of 47.38K.
Shane Barton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Shane Barton holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Shane Barton
Shane Barton's Trading History
Precision BioSciences
Jun 09, 2023
VP & Corp. Contr
Uninformative Buy
4.72K
$138.89K
BioAge Labs, Inc.
Mar 10, 2025
CAO
Informative Buy
47.38K
$11.05K
List of latest transactions for each holding click on a transaction to see Shane Barton's performance on stock
You May Also Like
Shane Barton insider profile FAQ
What is the percentage of profitable transactions made by Shane Barton?
The percentage of profitable transactions made by Shane Barton is ―.
What is the average return per transaction made by Shane Barton?
The average return per transaction made by Shane Barton is ―.
What stocks does Shane Barton hold?
Shane Barton holds: DTIL, BIOA stocks.
What was Shane Barton’s latest transaction?
Shane Barton latest transaction was an Informative Buy of $47.38K.
What was Shane Barton's most profitable transaction?
Shane Barton’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Shane Barton's role in Precision BioSciences?
Shane Barton's role in Precision BioSciences is VP & Corp. Contr.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.